Polen Capital Management
BSX icon

Polen Capital Management’s Boston Scientific BSX Stock Holding History

Polen Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Sell
4,750
-574,989
-99% -$31.2M ﹤0.01% 219
2026
Q1 		$36.4M Sell
579,739
-3,439,813
-86% -$275M 0.25% 31
2025
Q4 		$383M Sell
4,019,552
-1,578,734
-28% -$155M 1.64% 23
2025
Q3 		$547M Buy
+5,598,286
New +$580M 1.77% 22

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Polen Capital Management's BSX Position: Q2 2026 in Review

Polen Capital Management reduced its Boston Scientific (BSX) stake by 99% in Q2 2026, selling an estimated $31.2M and leaving 4,750 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #219.

Polen Capital Management first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $547M in Q3 2025. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Polen Capital Management held 4,750 shares of Boston Scientific worth $203K as of Q2 2026.
  • Polen Capital Management sold 574,989 Boston Scientific shares in Q2 2026, an estimated $31.2M.
  • Boston Scientific made up ﹤0.01% of Polen Capital Management's portfolio in Q2 2026, its #219 holding.
  • Polen Capital Management first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Polen Capital Management's Boston Scientific position peaked at $547M in Q3 2025.
  • 1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Polen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.